In such trials, the patient undergoes pairs of treatment periods organized so that one period involves
the use of the experimental treatment and the other involves the use of an alternate or placebo
therapy. The patient and physicians are blinded, if possible, and outcomes are monitored.
Treatment periods are replicated until the clinician and patient are convinced that the treatments
are definitely different or definitely not different.
Proportion of people with a negative test result who are free of the target disorder.
The number of patients that need to be treated with a specified therapy in order to prevent one
additional bad outcome. Calculated as the inverse of the absolute risk reduction (1/ARR).
Return to EBM Tool Kit
Medical Center Library
Duke University
Last modified on: 16-Dec-04